Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia

BACKGROUND: Aurothioglucose- (ATG-) mediated inhibition of thioredoxin reductase-1 (TXNRD1) improves alveolarization in experimental murine bronchopulmonary dysplasia (BPD). Glutathione (GSH) mediates susceptibility to neonatal and adult oxidative lung injury. We have previously shown that ATG atten...

Descripción completa

Detalles Bibliográficos
Autores principales: Wall, Stephanie B., Wood, Rachael, Dunigan, Katelyn, Li, Qian, Li, Rui, Rogers, Lynette K., Tipple, Trent E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360549/
https://www.ncbi.nlm.nih.gov/pubmed/30805084
http://dx.doi.org/10.1155/2019/7945983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360549/
https://www.ncbi.nlm.nih.gov/pubmed/30805084
http://dx.doi.org/10.1155/2019/7945983

Ejemplares similares